print small

Participating Countries:

Australia

Belarus

Belgium

Bulgaria

Croatia

Cyprus

Czech Republic

Estonia

France

Germany

Greece

Hungary

Iceland

Ireland

Israel

Italy

Japan

Lithuania

Luxembourg

Malta

Netherlands

Poland

Portugal

Romania

Russian Federation

Serbia

Slovakia

Slovenia

Spain

Sweden

Turkey

Ukraine

United Kingdom

United States

4/14/2017 (Added to site)
Author(s): S. Vermeylen, J. De Waele, S. Vanuytsel, J. De Backer, J. Van der Paal, M. Ramakers, K. Leyssens, E. Marcq, J. Van Audenaerde, E. L. J. Smits, S. Dewilde and A. Bogaerts

Cold atmospheric plasma treatment of melanoma and glioblastoma cancer cells

Journal: Plasma Process. Polym. 13: 1195–1205 (2016)
DOI: 10.1002/ppap.201600116
Request reprint

In this  paper, two types of melanoma and glioblastoma cancer cell lines are treated with cold atmospheric plasma to assess the effect of several parameters on the cell viability. The cell viability decreases with treatment duration and time until analysis in all cell lines with varying sensitivity. The majority of dead cells stains both AnnexinV (AnnV) and propidium iodide, indicating that the plasma-treated non-viable cells are mostly late apoptotic or necrotic. Genetic mutations might be involved in the response to plasma. Comparing the effects of two gas mixtures, as well as indirect plasma-activated medium versus direct treatment, gives different results per cell line. In conclusion, this study confirms the potential of plasma for cancer therapy and emphasizes the influence of experimental parameters on therapeutic outcome.


Keywords: biomedical applications   

Action Office

Working groups

Core Group

Related sites: